Search
for
Sort by
Research 91–120 of 432
- A local drug delivery system based on visible light-cured glycol chitosan and doxorubicin⋅hydrochloride for thyroid cancer treatment <i>in vitro</i> and <i>in vivo</i>
- Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation
- 3D Microtumors Representing Ovarian Cancer Minimal Residual Disease Respond to the Fatty Acid Oxidation Inhibitor Perhexiline
- SAT-080 An Atypical Adenoma Presenting with Hyperandrogenism: A Rare Case Presentation on a Pituitary Germ Cell Tumor
- Liquid Protein Diets and Telogen Effluvium: A Case Report
- Applications of Nanostructured Lipid Carriers: Recent Advancements and Patent Review
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Alopecia With Endocrine Therapies in Patients With Cancer
- Clinical Development of Topoisomerase-Interactive Drugs
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Nanocarriers for Improved Delivery of Angiotensin-(1-7)
- Synthesis and Structure–Activity Relationships of the First Ferrocenyl-Aryl-Hydantoin Derivatives of the Nonsteroidal Antiandrogen Nilutamide
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil
- Management of Toxicities of Targeted Therapies
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Cytostatics and immunosuppressive drugs
- Industry update: the latest developments in the field of therapeutic delivery, July 2018
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Fibroblast heterogeneity and functions: insights from single-cell sequencing in wound healing, breast cancer, ovarian cancer and melanoma
- Drug-Induced Skin, Nail and Hair Disorders
- A Review on Hydrogels with Photothermal Effect in Wound Healing and Bone Tissue Engineering
- Microneedle-Based Approaches for Skin Disease Treatment
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Transdermal Composite Microneedle Composed of Mesoporous Iron Oxide Nanoraspberry and PVA for Androgenetic Alopecia Treatment
- Venous thromboembolism and women's health